Myeloperoxidase: A leukocyte-derived protagonist of inflammation and cardiovascular disease

Antioxidants and Redox Signaling

Volumn 18, Issue 6, 2013, Pages 692-713

  Nussbaum, Claudia ^a   Klinke, Anna ^b   Adam, Matti ^b   Baldus, Stephan ^b   Sperandio, Markus ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HEART CENTER HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN G; CD18 ANTIGEN; GAMMA INTERFERON; GELATINASE A; GELATINASE B; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LEUKOCYTE ELASTASE; LOW DENSITY LIPOPROTEIN; LYSOZYME; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BACTERICIDAL ACTIVITY; CARDIOVASCULAR DISEASE; CATALYSIS; CELL FUNCTION; CHLORINATION; CYTOKINE PRODUCTION; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ENZYME STRUCTURE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; INFLAMMATION; LEUKOCYTE; MACROPHAGE; MONOCYTE; NONHUMAN; OXIDATION; PHAGOSOME; PRIORITY JOURNAL; REVIEW;

CARDIOVASCULAR DISEASES; HUMANS; HYPOCHLOROUS ACID; INFECTION; INFLAMMATION; LEUKOCYTES; NEUTROPHILS; PEROXIDASE;

EID: 84872451042     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4783     Document Type: Review

References (250)

1. Abu-Soud HM and Hazen SL. Nitric oxide modulates the catalytic activity of myeloperoxidase. J Biol Chem 275: 5425-5430, 2000. (Pubitemid 30115174)
2. Abu-Soud HM and Hazen SL. Interrogation of heme pocket environment of mammalian peroxidases with diatomic ligands. Biochemistry 40: 10747-10755, 2001. (Pubitemid 32835015)
3. Agner K. Verdoperoxidase: a ferment isolated from neutrophils. Acta Physiol Scand 2, Suppl 8: 1-62, 1941.
4. Allegra M, Furtmuller PG, Jantschko W, Zederbauer M, Tesoriere L, Livrea MA, and Obinger C. Mechanism of interaction of betanin and indicaxanthin with human myeloperoxidase and hypochlorous acid. Biochem Biophys Res Commun 332: 837-844, 2005. (Pubitemid 40745189)
5. Andersson E, Hellman L, Gullberg U, and Olsson I. The role of the propeptide for processing and sorting of human myeloperoxidase. J Biol Chem 273: 4747-4753, 1998. (Pubitemid 28103224)
6. Apple FS, Smith SW, Pearce LA, Schulz KM, Ler R, and Murakami MM. Myeloperoxidase improves risk stratification in patients with ischemia and normal cardiac troponin I concentrations. Clin Chem 57: 603-608, 2011.
7. Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, Tate J, Pagani F, Christenson RH, Mockel M, Danne O, and Jaffe AS. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 51: 810-824, 2005. (Pubitemid 40577917)
8. Aratani Y, Kura F, Watanabe H, Akagawa H, Takano Y, Suzuki K, Dinauer MC, Maeda N, and Koyama H. Critical role of myeloperoxidase and nicotinamide adenine dinucleotide phosphate-oxidase in high-burden systemic infection of mice with Candida albicans. J Infect Dis 185: 1833-1837, 2002. (Pubitemid 34615484)
9. Aratani Y, Kura F, Watanabe H, Akagawa H, Takano Y, Suzuki K, Dinauer MC, Maeda N, and Koyama H. Relative contributions of myeloperoxidase and NADPH-oxidase to the early host defense against pulmonary infections with Candida albicans and Aspergillus fumigatus. Med Mycol 40: 557-563, 2002. (Pubitemid 36050146)
10. Aratani Y, Kura F, Watanabe H, Akagawa H, Takano Y, Suzuki K, Dinauer MC, Maeda N, and Koyama H. In vivo role of myeloperoxidase for the host defense. Jpn J Infect Dis 57: S15, 2004.
11. Arnhold J and Flemmig J. Human myeloperoxidase in innate and acquired immunity. Arch Biochem Biophys 500: 92-106, 2010.
12. Arnljots K and Olsson I. Myeloperoxidase precursors incorporate heme. J Biol Chem 262: 10430-10433, 1987. (Pubitemid 17127035)
13. Arslan F, de Kleijn DP, and Pasterkamp G. Innate immune signaling in cardiac ischemia. Nat Rev Cardiol 8: 292-300, 2011.
14. Askari AT, Brennan ML, Zhou X, Drinko J, Morehead A, Thomas JD, Topol EJ, Hazen SL, and Penn MS. Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction. J Exp Med 197: 615-624, 2003. (Pubitemid 36314656)
15. Astern JM, Pendergraft WF, III, Falk RJ, Jennette JC, Schmaier AH, Mahdi F, and Preston GA. Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma Kallikrein- Kinin system. Am J Pathol 171: 349-360, 2007. (Pubitemid 47339251)
16. Austin GE, Zhao WG, Adjiri A, and Lu JP. Control of myeloperoxidase gene expression in developing myeloid cells. Leuk Res 20: 817-820, 1996. (Pubitemid 26400201)
17. Baldus S, Eiserich JP, Mani A, Castro L, Figueroa M, Chumley P, Ma W, Tousson A, White CR, Bullard DC, Brennan ML, Lusis AJ, Moore KP, and Freeman BA. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest 108: 1759-1770, 2001. (Pubitemid 34015121)
18. Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Munzel T, Simoons ML, and Hamm CW. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108: 1440-1445, 2003. (Pubitemid 37176448)
19. Baldus S, Heitzer T, Eiserich JP, Lau D, Mollnau H, Ortak M, Petri S, Goldmann B, Duchstein HJ, Berger J, Helmchen U, Freeman BA, Meinertz T, and Munzel T. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radic Biol Med 37: 902-911, 2004. (Pubitemid 39078559)
20. Baldus S, Rudolph V, Roiss M, Ito WD, Rudolph TK, Eiserich JP, Sydow K, Lau D, Szocs K, Klinke A, Kubala L, Berglund L, Schrepfer S, Deuse T, Haddad M, Risius T, Klemm H, Reichenspurner HC, Meinertz T, and Heitzer T. Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation 113: 1871-1878, 2006. (Pubitemid 43739399)
21. Ballieux BE, Zondervan KT, Kievit P, Hagen EC, van Es LA, van der Woude FJ, and Daha MR. Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCAmediated endothelial damage through ADCC? Clin Exp Immunol 97: 52-60, 1994. (Pubitemid 24244055)
22. Bergt C, Pennathur S, Fu X, Byun J, O'Brien K, McDonald TO, Singh P, Anantharamaiah GM, Chait A, Brunzell J, Geary RL, Oram JF, and Heinecke JW. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci U S A 101: 13032-13037, 2004. (Pubitemid 39167578)
23. Bergt C, Reicher H, Malle E, and Sattler W. Hypochlorite modification of high density lipoprotein: effects on cholesterol efflux from J774 macrophages. FEBS Lett 452: 295-300, 1999. (Pubitemid 29301763)
24. Biffl WL, Moore EE, Moore FA, and Barnett C. Nitric oxide reduces endothelial expression of intercellular adhesion molecule (ICAM)-1. J Surg Res 63: 328-332, 1996. (Pubitemid 26197215)
25. Bolscher BG and Wever R. A kinetic study of the reaction between human myeloperoxidase, hydroperoxides and cyanide. Inhibition by chloride and thiocyanate. Biochim Biophys Acta 788: 1-10, 1984. (Pubitemid 14097526)
26. Booth KS, Kimura S, Lee HC, Ikeda-Saito M, and Caughey WS. Bovine myeloperoxidase and lactoperoxidase each contain a high affinity site for calcium. Biochem Biophys Res Commun 160: 897-902, 1989.
27. Bos A, Wever R, and Roos D. Characterization and quantification of the peroxidase in human monocytes. Biochim Biophys Acta 525: 37-44, 1978. (Pubitemid 8370729)
28. Brennan ML, Anderson MM, Shih DM, Qu XD, Wang X, Mehta AC, Lim LL, Shi W, Hazen SL, Jacob JS, Crowley JR, Heinecke JW, and Lusis AJ. Increased atherosclerosis in myeloperoxidase-deficient mice. J Clin Invest 107: 419-430, 2001. (Pubitemid 32167988)
29. Brennan ML, Penn MS, Van LF, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, Nissen SE, and Hazen SL. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349: 1595-1604, 2003. (Pubitemid 37288567)
30. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, and Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 303: 1532-1535, 2004. (Pubitemid 38314426)
31. Brinkmann V and Zychlinsky A. Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol 5: 577-582, 2007. (Pubitemid 47074113)
32. Brugger-Andersen T, Aarsetoy H, Grundt H, Staines H, and Nilsen DW. The long-term prognostic value of multiple biomarkers following a myocardial infarction. Thromb Res 123: 60-66, 2008.
33. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, and Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 347: 5-12, 2002. (Pubitemid 34728951)
34. Bulow E, Nauseef WM, Goedken M, McCormick S, Calafat J, GullbergU, and Olsson I. Sorting for storage in myeloid cells of nonmyeloid proteins and chimeras with the propeptide of myeloperoxidase precursor. J Leukoc Biol 71: 279-288, 2002.
35. Burner U, Furtmuller PG, Kettle AJ, Koppenol WH, and Obinger C. Mechanism of reaction of myeloperoxidase with nitrite. J Biol Chem 275: 20597-20601, 2000. (Pubitemid 30457644)
36. Burner U, Obinger C, Paumann M, Furtmuller PG, and Kettle AJ. Transient and steady-state kinetics of the oxidation of substituted benzoic acid hydrazides by myeloperoxidase. J Biol Chem 274: 9494-9502, 1999.
37. Campuzano O, Castillo-Ruiz MM, Acarin L, Gonzalez B, and Castellano B. Decreased myeloperoxidase expressing cells in the aged rat brain after excitotoxic damage. Exp Gerontol 46: 723-730, 2011.
38. Cavusoglu E, Ruwende C, Eng C, Chopra V, Yanamadala S, Clark LT, Pinsky DJ, and Marmur JD. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome. Am J Cardiol 99: 1364-1368, 2007. (Pubitemid 46686633)
39. Chang CY, Song MJ, Jeon SB, Yoon HJ, Lee DK, Kim IH, Suk K, Choi DK, and Park EJ. Dual functionality of myeloperoxidase in rotenone-exposed brain-resident immune cells. Am J Pathol 179: 964-979, 2011.
40. Chang LT, Chua S, Sheu JJ, Wu CJ, Yeh KH, Yang CH, and Yip HK. Level and prognostic value of serum myeloperoxidase in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Circ J 73: 726-731, 2009.
41. Chapman AL, Hampton MB, Senthilmohan R, Winterbourn CC, and Kettle AJ. Chlorination of bacterial and neutrophil proteins during phagocytosis and killing of Staphylococcus aureus. J Biol Chem 277: 9757-9762, 2002. (Pubitemid 34968078)
42. Chapman AL, Morrissey BM, Vasu VT, Juarez MM, Houghton JS, Li CS, Cross CE, and Eiserich JP. Myeloperoxidase- dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway. J Cyst Fibros 9: 84-92, 2010.
43. Chapman AL, Skaff O, Senthilmohan R, Kettle AJ, and Davies MJ. Hypobromous acid and bromamine production by neutrophils and modulation by superoxide. Biochem J 417: 773-781, 2009.
44. Chen J, Fu X, Wang Y, Ling M, McMullen B, Kulman J, Chung DW, and Lopez JA. Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13. Blood 115: 706-712, 2010.
45. Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, Patel KD, Chakrabarti S, McAvoy E, Sinclair GD, Keys EM, len-Vercoe E, Devinney R, Doig CJ, Green FH, and Kubes P. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 13: 463-469, 2007. (Pubitemid 46559832)
46. Curtis MP, Hicks AJ, and Neidigh JW. Kinetics of 3-chlorotyrosine formation and loss due to hypochlorous acid and chloramines. Chem Res Toxicol 24: 418-428, 2011.
47. Daphna EM, Michaela S, Eynat P, Irit A, and Rimon S. Association of myeloperoxidase with heparin: oxidative inactivation of proteins on the surface of endothelial cells by the bound enzyme. Mol Cell Biochem 183: 55-61, 1998. (Pubitemid 28263887)
48. David A, Kacher Y, Specks U, and Aviram I. Interaction of proteinase 3 with CD11b/CD18 (beta2 integrin) on the cell membrane of human neutrophils. J Leukoc Biol 74: 551-557, 2003. (Pubitemid 38040382)
49. Davies MJ. Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention. J Clin Biochem Nutr 48: 8-19, 2011.
50. Davies MJ, Hawkins CL, Pattison DI, and Rees MD. Mammalian heme peroxidases: from molecular mechanisms to health implications. Antioxid Redox Signal 10: 1199-1234, 2008. (Pubitemid 351634397)
51. de Jong S, van Veen TA, van Rijen HV, and de Bakker JM. Fibrosis and cardiac arrhythmias. J Cardiovasc Pharmacol 57: 630-638, 2011.
52. Dever GJ, Benson R, Wainwright CL, Kennedy S, and Spickett CM. Phospholipid chlorohydrin induces leukocyte adhesion to ApoE-/- mouse arteries via upregulation of P-selectin. Free Radic Biol Med 44: 452-463, 2008.
53. Devitt A and Marshall LJ. The innate immune system and the clearance of apoptotic cells. J Leukoc Biol 90: 447-457, 2011.
54. Dominguez-Rodriguez A, Samimi-Fard S, Abreu-Gonzalez P, Garcia-Gonzalez MJ, and Kaski JC. Prognostic value of admission myeloperoxidase levels in patients with STsegment elevation myocardial infarction and cardiogenic shock. Am J Cardiol 101: 1537-1540, 2008.
55. Dri P, Cramer R, Menegazzi R, and Patriarca P. Increased degranulation of human myeloperoxidase-deficient polymorphonuclear leucocytes. Br J Haematol 59: 115-125, 1985. (Pubitemid 15188826)
56. Eggers KM, Dellborg M, Johnston N, Oldgren J, Swahn E, Venge P, and Lindahl B. Myeloperoxidase is not useful for the early assessment of patients with chest pain. Clin Biochem 43: 240-245, 2010.
57. Eiserich JP, Baldus S, Brennan ML, Ma W, Zhang C, Tousson A, Castro L, Lusis AJ, Nauseef WM, White CR, and Freeman BA. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296: 2391-2394, 2002. (Pubitemid 34734213)
58. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, and Van der Vliet A. Formation of nitric oxidederived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391: 393-397, 1998. (Pubitemid 28093514)
59. El Kebir D, Jozsef L, Pan W, and Filep JG. Myeloperoxidase delays neutrophil apoptosis through CD11b/CD18 integrins and prolongs inflammation. Circ Res 103: 352-359, 2008.
60. El Kebir D, Jozsef L, Pan W, Wang L, Petasis NA, Serhan CN, and Filep JG. 15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury. Am J Respir Crit Care Med 180: 311-319, 2009.
61. Ermak N, Lacour B, Drueke TB, and Vicca S. Role of reactive oxygen species and Bax in oxidized low density lipoprotein- induced apoptosis of human monocytes. Atherosclerosis 200: 247-256, 2008.
62. Farrell AJ, Blake DR, Palmer RM, and Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51: 1219-1222, 1992.
63. Fenna R, Zeng J, and Davey C. Structure of the green heme in myeloperoxidase. Arch Biochem Biophys 316: 653-656, 1995.
64. Fiedler TJ, Davey CA, and Fenna RE. X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 A resolution. J Biol Chem 275: 11964-11971, 2000. (Pubitemid 30237768)
65. Furtmuller PG, Arnhold J, Jantschko W, Pichler H, and Obinger C. Redox properties of the couples compound I/ compound II and compound II/native enzyme of human myeloperoxidase. Biochem Biophys Res Commun 301: 551-557, 2003. (Pubitemid 36279276)
66. Furtmuller PG, Jantschko W, Zederbauer M, Jakopitsch C, Arnhold J, and Obinger C. Kinetics of interconversion of redox intermediates of lactoperoxidase, eosinophil peroxidase and myeloperoxidase. Jpn J Infect Dis 57: S30-S31, 2004. (Pubitemid 39545725)
67. Furtmuller PG, Zederbauer M, Jantschko W, Helm J, Bogner M, Jakopitsch C, and Obinger C. Active site structure and catalytic mechanisms of human peroxidases. Arch Biochem Biophys 445: 199-213, 2006. (Pubitemid 43082213)
68. Gelderman MP, Stuart R, Vigerust D, Fuhrmann S, Lefkowitz DL, Allen RC, Lefkowitz SS, and Graham S. Perpetuation of inflammation associated with experimental arthritis: the role of macrophage activation by neutrophilic myeloperoxidase. Mediators Inflamm 7: 381-389, 1998. (Pubitemid 29030350)
69. Gomez-Mejiba SE, Zhai Z, Gimenez MS, Ashby MT, Chilakapati J, Kitchin K, Mason RP, and Ramirez DC. Myeloperoxidase- induced genomic DNA-centered radicals. J Biol Chem 285: 20062-20071, 2010.
70. Grattendick K, Stuart R, Roberts E, Lincoln J, Lefkowitz SS, Bollen A, Moguilevsky N, Friedman H, and Lefkowitz DL. Alveolar macrophage activation by myeloperoxidase: a model for exacerbation of lung inflammation. Am J Respir Cell Mol Biol 26: 716-722, 2002. (Pubitemid 34557373)
71. Green PS, Mendez AJ, Jacob JS, Crowley JR, Growdon W, Hyman BT, and Heinecke JW. Neuronal expression of myeloperoxidase is increased in Alzheimer's disease. J Neurochem 90: 724-733, 2004. (Pubitemid 38989404)
72. Gumiero A, Metcalfe CL, Pearson AR, Raven EL, and Moody PC. Nature of the ferryl heme in compounds I and II. J Biol Chem 286: 1260-1268, 2011.
73. Gupta AK, Hasler P, Holzgreve W, Gebhardt S, and Hahn S. Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia. Hum Immunol 66: 1146-1154, 2005.
74. Haegens A, Heeringa P, van Suylen RJ, Steele C, Aratani Y, O'Donoghue RJ, Mutsaers SE, Mossman BT, Wouters EF, and Vernooy JH. Myeloperoxidase deficiency attenuates lipopolysaccharide-induced acute lung inflammation and subsequent cytokine and chemokine production. J Immunol 182: 7990-7996, 2009.
75. Hagiwara N. Inflammation and atrial fibrillation. Circ J 74: 246-247, 2010.
76. Hakkim A, Furnrohr BG, Amann K, Laube B, Abu AU, Brinkmann V, Herrmann M, Voll RE, and Zychlinsky A. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A 107: 9813-9818, 2010.
77. Hampton MB, Kettle AJ, and Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92: 3007-3017, 1998. (Pubitemid 28492304)
78. Hansson M, Olsson I, and Nauseef WM. Biosynthesis, processing, and sorting of human myeloperoxidase. Arch Biochem Biophys 445: 214-224, 2006. (Pubitemid 43082214)
79. Hawkins CL, Pattison DI, and Davies MJ. Hypochloriteinduced oxidation of amino acids, peptides and proteins. Amino Acids 25: 259-274, 2003. (Pubitemid 38041264)
80. Hazell LJ, Arnold L, Flowers D, Waeg G, Malle E, and Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest 97: 1535-1544, 1996. (Pubitemid 26097044)
81. Hazell LJ and Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem J 290 (Pt 1): 165-172, 1993. (Pubitemid 23081215)
82. Hazen SL. Neutrophils, hypercholesterolemia, and atherogenesis. Circulation 122: 1786-1788, 2010.
83. Hazen SL and Heinecke JW. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 99: 2075-2081, 1997. (Pubitemid 27203762)
84. Hazen SL, Hsu FF, Mueller DM, Crowley JR, and Heinecke JW. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J Clin Invest 98: 1283-1289, 1996. (Pubitemid 26322052)
85. Hazen SL, Zhang R, Shen Z, Wu W, Podrez EA, Mac- Pherson JC, Schmitt D, Mitra SN, Mukhopadhyay C, Chen Y, Cohen PA, Hoff HF, and Abu-Soud HM. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo. Circ Res 85: 950-958, 1999. (Pubitemid 29534170)
86. Heslop CL, Frohlich JJ, and Hill JS. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. J Am Coll Cardiol 55: 1102-1109, 2010.
87. Hirche TO, Gaut JP, Heinecke JW, and Belaaouaj A. Myeloperoxidase plays critical roles in killing Klebsiella pneumoniae and inactivating neutrophil elastase: effects on host defense. J Immunol 174: 1557-1565, 2005.
88. Hoy A, Leininger-Muller B, Kutter D, Siest G, and Visvikis S. Growing significance of myeloperoxidase in noninfectious diseases. Clin Chem Lab Med 40: 2-8, 2002. (Pubitemid 34196441)
89. Ikeda-Saito M. Spectroscopic, ligand binding, and enzymatic properties of the spleen green hemeprotein. A comparison with myeloperoxidase. J Biol Chem 260: 11688-11696, 1985. (Pubitemid 16250827)
90. Ikeda-Saito M, Lee HC, Adachi K, Eck HS, Prince RC, Booth KS, Caughey WS, and Kimura S. Demonstration that spleen green hemeprotein is identical to granulocyte myeloperoxidase. J Biol Chem 264: 4559-4563, 1989. (Pubitemid 19081359)
91. Ishii Y, Schuessler RB, Gaynor SL, Yamada K, Fu AS, Boineau JP, and Damiano RJ, Jr. Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation 111: 2881-2888, 2005. (Pubitemid 40814180)
92. Jantschko W, Furtmuller PG, Zederbauer M, Jakopitsch C, and Obinger C. Kinetics of oxygen binding to ferrous myeloperoxidase. Arch Biochem Biophys 426: 91-97, 2004. (Pubitemid 38595134)
93. Jantschko W, Furtmuller PG, Zederbauer M, Neugschwandtner K, Lehner I, Jakopitsch C, Arnhold J, and Obinger C. Exploitation of the unusual thermodynamic properties of human myeloperoxidase in inhibitor design. Biochem Pharmacol 69: 1149-1157, 2005. (Pubitemid 40417486)
94. Jiang Q, Griffin DA, Barofsky DF, and Hurst JK. Intraphagosomal chlorination dynamics and yields determined using unique fluorescent bacterial mimics. Chem Res Toxicol 10: 1080-1089, 1997. (Pubitemid 27449510)
95. Jiang Q and Hurst JK. Relative chlorinating, nitrating, and oxidizing capabilities of neutrophils determined with phagocytosable probes. J Biol Chem 272: 32767-32772, 1997. (Pubitemid 28023608)
96. Johansson MW, Patarroyo M, Oberg F, Siegbahn A, and Nilsson K. Myeloperoxidase mediates cell adhesion via the alpha(m)beta(2) integrin (mac-1, cd11b/cd18). J Cell Sci 110: 1133-1139, 1997. (Pubitemid 27232283)
97. Johnson RJ, Guggenheim SJ, Klebanoff SJ, Ochi RF, Wass A, Baker P, Schulze M, and Couser WG. Morphologic correlates of glomerular oxidant injury induced by the myeloperoxidase- hydrogen peroxide-halide system of the neutrophil. Lab Invest 58: 294-301, 1988.
98. Kanayama A and Miyamoto Y. Apoptosis triggered by phagocytosis-related oxidative stress through FLIPS downregulation and JNK activation. J Leukoc Biol 82: 1344-1352, 2007. (Pubitemid 350133532)
99. Kang JI, Jr. and Neidigh JW. Hypochlorous acid damages histone proteins forming 3-chlorotyrosine and 3,5-dichlorotyrosine. Chem Res Toxicol 21: 1028-1038, 2008.
100. Kennedy AD and Deleo FR. Neutrophil apoptosis and the resolution of infection. Immunol Res 43: 25-61, 2009.
101. Kessenbrock K, Krumbholz M, Schonermarck U, Back W, Gross WL, Werb Z, Grone HJ, Brinkmann V, and Jenne DE. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 15: 623-625, 2009.
102. Kettle AJ. Neutrophils convert tyrosyl residues in albumin to chlorotyrosine. FEBS Lett 379: 103-106, 1996. (Pubitemid 26033928)
103. Kettle AJ, Anderson RF, Hampton MB, and Winterbourn CC. Reactions of superoxide with myeloperoxidase. Biochemistry 46: 4888-4897, 2007. (Pubitemid 46651210)
104. Kettle AJ and Winterbourn CC. Superoxide modulates the activity of myeloperoxidase and optimizes the production of hypochlorous acid. Biochem J 252: 529-536, 1988.
105. Khan IA. Atrial fibrillation: interaction between the trigger and the substrate. Int J Cardiol 87: 301-302, 2003. (Pubitemid 36135993)
106. Khan SQ, Kelly D, Quinn P, Davies JE, and Ng LL. Myeloperoxidase aids prognostication togetherwithN-terminal pro- B-type natriuretic peptide in high-risk patients with acute ST elevation myocardial infarction. Heart 93: 826-831, 2007. (Pubitemid 46998982)
107. King CC, Jefferson MM, and Thomas EL. Secretion and inactivation of myeloperoxidase by isolated neutrophils. J Leukoc Biol 61: 293-302, 1997. (Pubitemid 27149908)
108. Klebanoff SJ. Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes. Science 169: 1095-1097, 1970.
109. Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol 77: 598-625, 2005. (Pubitemid 40628741)
110. 2-chloride system. Am J Pathol 143: 907-917, 1993. (Pubitemid 24058246)
111. Klinke A, Nussbaum C, Kubala L, Friedrichs K, Rudolph TK, Rudolph V, Paust HJ, Schroder C, Benten D, Lau D, Szocs K, Furtmuller PG, Heeringa P, Sydow K, Duchstein HJ, Ehmke H, Schumacher U, Meinertz T, Sperandio M, and Baldus S. Myeloperoxidase attracts neutrophils by physical forces. Blood 117: 1350-1358, 2011.
112. Kooter IM, Koehler BP, Moguilevsky N, Bollen A, Wever R, and Johnson MK. The Met243 sulfonium ion linkage is responsible for the anomalous magnetic circular dichroism and optical spectral properties of myeloperoxidase. J Biol Inorg Chem 4: 684-691, 1999.
113. Kooter IM, Moguilevsky N, Bollen A, Sijtsema NM, Otto C, Dekker HL, and Wever R. Characterization of the Asp94 and Glu242 mutants in myeloperoxidase, the residues linking the heme group via ester bonds. Eur J Biochem 264: 211-217, 1999. (Pubitemid 29385884)
114. Kubala L, Lu G, Baldus S, Berglund L, and Eiserich JP. Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease. Clin Chim Acta 394: 59-62, 2008.
115. Kubala L, Schmelzer KR, Klinke A, Kolarova H, Baldus S, Hammock BD, and Eiserich JP. Modulation of arachidonic and linoleic acid metabolites in myeloperoxidase-deficient mice during acute inflammation. Free Radic Biol Med 48: 1311-1320, 2010.
116. Kubes P, Sihota E, and Hickey MJ. Endogenous but not exogenous nitric oxide decreases TNF-alpha- induced leukocyte rolling. Am J Physiol 36: G628-G635, 1997. (Pubitemid 27418782)
117. Kutter D, Devaquet P, Vanderstocken G, Paulus JM, Marchal V, and Gothot A. Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit? Acta Haematol 104: 10-15, 2000.
118. Lane AE, Tan JT, Hawkins CL, Heather AK, and Davies MJ. The myeloperoxidase-derived oxidant HOSCN inhibits protein tyrosine phosphatases and modulates cell signalling via the mitogen-activated protein kinase (MAPK) pathway in macrophages. Biochem J 430: 161-169, 2010.
119. Lanza F. Clinical manifestation of myeloperoxidase deficiency. J Mol Med (Berl) 76: 676-681, 1998. (Pubitemid 28412745)
120. Lau D and Baldus S. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol Ther 111: 16-26, 2006. (Pubitemid 43765542)
121. Lau D, Mollnau H, Eiserich JP, Freeman BA, Daiber A, Gehling UM, Brummer J, Rudolph V, Munzel T, Heitzer T, Meinertz T, and Baldus S. Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci U S A 102: 431-436, 2005. (Pubitemid 40116784)
122. Leeuwenburgh C, Hardy MM, Hazen SL, Wagner P, Ohishi S, Steinbrecher UP, and Heinecke JW. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem 272: 1433-1436, 1997. (Pubitemid 27043215)
123. Lefkowitz DL, Gelderman MP, Fuhrmann SR, Graham S, Starnes JD, III, Lefkowitz SS, Bollen A, and Moguilevsky N. Neutrophilic myeloperoxidase- macrophage interactions perpetuate chronic inflammation associated with experimental arthritis. Clin Immunol 91: 145-155, 1999. (Pubitemid 29203413)
124. Lefkowitz DL and Lefkowitz SS. Macrophage-neutrophil interaction: a paradigm for chronic inflammation revisited. Immunol Cell Biol 79: 502-506, 2001. (Pubitemid 34225145)
125. Lefkowitz DL and Lefkowitz SS. Microglia and myeloperoxidase: a deadly partnership in neurodegenerative disease. Free Radic Biol Med 45: 726-731, 2008.
126. Lefkowitz DL, Lincoln JA, Lefkowitz SS, Bollen A, and Moguilevsky N. Enhancement of macrophage-mediated bactericidal activity by macrophage-mannose receptor-ligand interaction. Immunol Cell Biol 75: 136-141, 1997. (Pubitemid 27191853)
127. Lefkowitz DL, Mills K, Morgan D, and Lefkowitz SS. Macrophage activation and immunomodulation by myeloperoxidase. Proc Soc Exp Biol Med 199: 204-210, 1992.
128. Lefkowitz DL, Roberts E, Grattendick K, Schwab C, Stuart R, Lincoln J, Allen RC, Moguilevsky N, Bollen A, and Lefkowitz SS. The endothelium and cytokine secretion: the role of peroxidases as immunoregulators. Cell Immunol 202: 23-30, 2000. (Pubitemid 30445643)
129. Lefkowitz SS, Gelderman MP, Lefkowitz DL, Moguilevsky N, and Bollen A. Phagocytosis and intracellular killing of Candida albicans by macrophages exposed to myeloperoxidase. J Infect Dis 173: 1202-1207, 1996. (Pubitemid 26251464)
130. Lehrer RI, Hanifin J, and Cline MJ. Defective bactericidal activity in myeloperoxidase-deficient human neutrophils. Nature 223: 78-79, 1969.
131. Ley K, Laudanna C, Cybulsky MI, and Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7: 678-689, 2007. (Pubitemid 47327397)
132. Lloyd MM, van Reyk DM, Davies MJ, and Hawkins CL. Hypothiocyanous acid is a more potent inducer of apoptosis and protein thiol depletion in murine macrophage cells than hypochlorous acid or hypobromous acid. Biochem J 414: 271-280, 2008.
133. Locksley RM, Nelson CS, Fankhauser JE, and Klebanoff SJ. Loss of granule myeloperoxidase during in vitro culture of human monocytes correlates with decay in antiprotozoa activity. Am J Trop Med Hyg 36: 541-548, 1987. (Pubitemid 17099468)
134. 2 in antigen-induced arthritis. Arthritis Rheum 63: 2651-2660, 2011.
135. Maitra D, Banerjee J, Shaeib F, Souza CE, and Abu-Soud HM. Melatonin can mediate its vascular protective effect by modulating free iron level by inhibiting hypochlorous acidmediated hemoprotein heme destruction. Hypertension 57: e22, 2011.
136. Maki RA, Tyurin VA, Lyon RC, Hamilton RL, DeKosky ST, Kagan VE, and Reynolds WF. Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease. J Biol Chem 284: 3158-3169, 2009.
137. Manzenreiter R, Kienberger F, Marcos V, Schilcher K, Krautgartner WD, Obermayer A, Huml M, Stoiber W, Hector A, Griese M, Hannig M, Studnicka M, Vitkov L, and Hartl D. Ultrastructural characterization of cystic fibrosis sputum using atomic force and scanning electron microscopy. J Cyst Fibros 11: 84-92, 2012.
138. Marquez LA and Dunford HB. Cyanide binding to canine myeloperoxidase. Biochem Cell Biol 67: 187-191, 1989. (Pubitemid 19174744)
139. Marquez LA and Dunford HB. Kinetics of oxidation of tyrosine and dityrosine by myeloperoxidase compounds I and II. Implications for lipoprotein peroxidation studies. J Biol Chem 270: 30434-30440, 1995.
140. Marquez LA, Huang JT, and Dunford HB. Spectral and kinetic studies on the formation of myeloperoxidase compounds I and II: roles of hydrogen peroxide and superoxide. Biochemistry 33: 1447-1454, 1994. (Pubitemid 24093692)
141. Matthijsen RA, Huugen D, Hoebers NT, de VB, Peutz- Kootstra CJ, Aratani Y, Daha MR, Tervaert JW, Buurman WA, and Heeringa P. Myeloperoxidase is critically involved in the induction of organ damage after renal ischemia reperfusion. Am J Pathol 171: 1743-1752, 2007.
142. McMillen TS, Heinecke JW, and LeBoeuf RC. Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice. Circulation 111: 2798-2804, 2005. (Pubitemid 40791552)
143. Meotti FC, Jameson GN, Turner R, Harwood DT, Stockwell S, Rees MD, Thomas SR, and Kettle AJ. Urate as a physiological substrate for myeloperoxidase: implications for hyperuricemia and inflammation. J Biol Chem 286: 12901-12911, 2011.
144. Metzler KD, Fuchs TA, Nauseef WM, Reumaux D, Roesler J, Schulze I, Wahn V, Papayannopoulos V, and Zychlinsky A. Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity. Blood 117: 953-959, 2011.
145. Meuwese MC, Stroes ES, Hazen SL, van Miert JN, Kuivenhoven JA, Schaub RG, Wareham NJ, Luben R, Kastelein JJ, Khaw KT, and Boekholdt SM. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 50: 159-165, 2007. (Pubitemid 47002189)
146. Midwinter RG, Vissers MC, and Winterbourn CC. Hypochlorous acid stimulation of the mitogen-activated protein kinase pathway enhances cell survival. Arch Biochem Biophys 394: 13-20, 2001. (Pubitemid 32948279)
147. Mocatta TJ, Pilbrow AP, Cameron VA, Senthilmohan R, Frampton CM, Richards AM, and Winterbourn CC. Plasma concentrations of myeloperoxidase predict mortal- ity after myocardial infarction. J Am Coll Cardiol 49: 1993-2000, 2007. (Pubitemid 46734639)
148. Morrow DA, Sabatine MS, Brennan ML, de Lemos JA, Murphy SA, Ruff CT, Rifai N, Cannon CP, and Hazen SL. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS- TIMI. Eur Heart J 29: 1096-1102, 2008. (Pubitemid 351844877)
149. Mott JD and Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16: 558-564, 2004. (Pubitemid 39201241)
150. Murphy EJ, Marechal A, Segal AW, and Rich PR. CO binding and ligand discrimination in human myeloperoxidase. Biochemistry 49: 2150-2158, 2010.
151. Nakazato T, Sagawa M, Yamato K, Xian M, Yamamoto T, Suematsu M, Ikeda Y, and Kizaki M. Myeloperoxidase is a key regulator of oxidative stress mediated apoptosis in myeloid leukemic cells. Clin Cancer Res 13: 5436-5445, 2007. (Pubitemid 47510371)
152. Narasaraju T, Yang E, Samy RP, Ng HH, Poh WP, Liew AA, Phoon MC, van RN, and Chow VT. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol 179: 199-210, 2011.
153. Nauseef WM. Insights into myeloperoxidase biosynthesis from its inherited deficiency. J Mol Med (Berl) 76: 661-668, 1998. (Pubitemid 28412743)
154. Nauseef WM. Contributions of myeloperoxidase to proinflammatory events: more than an antimicrobial system. Int J Hematol 74: 125-133, 2001. (Pubitemid 33760061)
155. Nauseef WM, Cogley M, and McCormick S. Effect of the R569W missense mutation on the biosynthesis of myeloperoxidase. J Biol Chem 271: 9546-9549, 1996. (Pubitemid 26137359)
156. Nauseef WM, Root RK, Newman SL, and Malech HL. Inhibition of zymosan activation of human neutrophil oxidative metabolism by a mouse monoclonal antibody. Blood 62: 635, 1983.
157. Ndrepepa G, Braun S, Mehilli J, von BN, Schomig A, and Kastrati A. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes. Eur J Clin Invest 38: 90-96, 2008. (Pubitemid 351143413)
158. Neve J, Parij N, and Moguilevsky N. Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs investigated with a human recombinant enzyme. Eur J Pharmacol 417: 37-43, 2001. (Pubitemid 32299866)
159. Ng LL, Pathik B, Loke IW, Squire IB, and Davies JE. Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure. Am Heart J 152: 94-101, 2006. (Pubitemid 43974728)
160. Nicholls SJ, Cutri B, Worthley SG, Kee P, Rye KA, Bao S, and Barter PJ. Impact of short-term administration of highdensity lipoproteins and atorvastatin on atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 25: 2416-2421, 2005. (Pubitemid 41552664)
161. Nicholls SJ, Zheng L, and Hazen SL. Formation of dysfunctional high-density lipoprotein by myeloperoxidase. Trends Cardiovasc Med 15: 212-219, 2005. (Pubitemid 41338008)
162. Odell EW and Segal AW. The bactericidal effects of the respiratory burst and the myeloperoxidase system isolated in neutrophil cytoplasts. Biochim Biophys Acta 971: 266-274, 1988.
163. Ogino T, Ozaki M, Hosako M, Omori M, Okada S, and Matsukawa A. Activation of c-Jun N-terminal kinase is essential for oxidative stress-induced Jurkat cell apoptosis by monochloramine. Leuk Res 33: 151-158, 2009.
164. Papayannopoulos V, Metzler KD, Hakkim A, and Zychlinsky A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol 191: 677-691, 2010.
165. Pattison DI, Hawkins CL, and Davies MJ. Hypochlorous acid-mediated oxidation of lipid components and antioxidants present in low-density lipoproteins: absolute rate constants, product analysis, and computational modeling. Chem Res Toxicol 16: 439-449, 2003. (Pubitemid 36514501)
166. Pattison DI, Hawkins CL, and Davies MJ. What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach. Chem Res Toxicol 22: 807-817, 2009.
167. Pennathur S, Bergt C, Shao B, Byun J, Kassim SY, Singh P, Green PS, McDonald TO, Brunzell J, Chait A, Oram JF, O'Brien K, Geary RL, and Heinecke JW. Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species. J Biol Chem 279: 42977-42983, 2004. (Pubitemid 39372190)
168. Podrez EA, Schmitt D, Hoff HF, and Hazen SL. Myeloperoxidase- generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest 103: 1547-1560, 1999.
169. Proteasa G, Tahboub YR, Galijasevic S, Raushel FM, and Abu-Soud HM. Kinetic evidence supports the existence of two halide binding sites that have a distinct impact on the heme iron microenvironment in myeloperoxidase. Biochemistry 46: 398-405, 2007. (Pubitemid 46115943)
170. Queiroz RF, Vaz SM, and Augusto O. Inhibition of the chlorinating activity of myeloperoxidase by tempol: revisiting the kinetics and mechanisms. Biochem J 439: 423-431, 2011.
171. Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci U S A 101: 4003-4008, 2004. (Pubitemid 38405874)
172. Rausch PG and Moore TG. Granule enzymes of polymorphonuclear neutrophils: a phylogenetic comparison. Blood 46: 913-919, 1975.
173. Ravnsborg T, Houen G, and Hojrup P. The glycosylation of myeloperoxidase. Biochim Biophys Acta 1804: 2046-2053, 2010.
174. Rees MD, Whitelock JM, Malle E, Chuang CY, Iozzo RV, Nilasaroya A, and Davies MJ. Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan. Matrix Biol 29: 63-73, 2010.
175. Reeves EP, Lu H, Jacobs HL, Messina CG, Bolsover S, Gabella G, Potma EO, Warley A, Roes J, and Segal AW. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 416: 291-297, 2002. (Pubitemid 34260237)
176. Reeves EP, Nagl M, Godovac-Zimmermann J, and Segal AW. Reassessment of the microbicidal activity of reactive oxygen species and hypochlorous acid with reference to the phagocytic vacuole of the neutrophil granulocyte. J Med Microbiol 52: 643-651, 2003. (Pubitemid 36981471)
177. Reichlin T, Socrates T, Egli P, Potocki M, Breidthardt T, Arenja N, Meissner J, Noveanu M, Reiter M, Twerenbold R, Schaub N, Buser A, and Mueller C. Use of myeloperoxidase for risk stratification in acute heart failure. Clin Chem 56: 944-951, 2010.
178. Resch U, Semlitsch M, Hammer A, Susani-Etzerodt H, Walczak H, Sattler W, and Malle E. Hypochlorite-modified lowdensity lipoprotein induces the apoptotic machinery in Jurkat T-cell lines. Biochem Biophys Res Commun 410: 895-900, 2011.
179. Roman RM, Camargo PV, Borges FK, Rossini AP, and Polanczyk CA. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients. Coron Artery Dis 21: 129-136, 2010.
180. Rosen H and Klebanoff SJ. Chemiluminescence and superoxide production by myeloperoxidase-deficient leukocytes. J Clin Invest 58: 50-60, 1976.
181. Rosen H, Klebanoff SJ, Wang Y, Brot N, Heinecke JW, and Fu X. Methionine oxidation contributes to bacterial killing by the myeloperoxidase system of neutrophils. Proc Natl Acad Sci U S A 106: 18686-18691, 2009.
182. Rudolph TK, Wipper S, Reiter B, Rudolph V, Coym A, Detter C, Lau D, Klinke A, Friedrichs K, Rau T, Pekarova M, Russ D, Knoll K, Kolk M, Schroeder B, Wegscheider K, Andresen H, Schwedhelm E, Boeger R, Ehmke H, and Baldus S. Myeloperoxidase deficiency preserves vasomotor function in humans. Eur Heart J 33: 1625-1634, 2011.
183. Rudolph V, Andrie RP, Rudolph TK, Friedrichs K, Klinke A, Hirsch-Hoffmann B, Schwoerer AP, Lau D, Fu X, Klingel K, Sydow K, Didie M, Seniuk A, von Leitner EC, Szoecs K, Schrickel JW, Treede H, Wenzel U, Lewalter T, Nickenig G, ZimmermannWH, Meinertz T, Boger RH, Reichenspurner H, Freeman BA, Eschenhagen T, Ehmke H, Hazen SL, Willems S, and Baldus S. Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med 16: 470-474, 2010.
184. Rudolph V, Rudolph TK, Hennings JC, Blankenberg S, Schnabel R, Steven D, Haddad M, Knittel K, Wende S, Wenzel J, Munzel T, Heitzer T, Meinertz T, Hubner C, and Baldus S. Activation of polymorphonuclear neutrophils in patients with impaired left ventricular function. Free Radic Biol Med 43: 1189-1196, 2007. (Pubitemid 47376907)
185. Rudolph V, Rudolph TK, Schopfer FJ, Bonacci G, Lau D, Szocs K, Klinke A, Meinertz T, Freeman BA, and Baldus S. Bivalirudin decreases NO bioavailability by vascular immobilization of myeloperoxidase. J Pharmacol Exp Ther 327: 324-331, 2008.
186. Sampson JB, Ye Y, Rosen H, and Beckman JS. Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide. Arch Biochem Biophys 356: 207-213, 1998. (Pubitemid 28387725)
187. Sawicki M, Sypniewska G, Kozinski M, Gruszka M, Krintus M, Obonska K, Pilaczynska-Cemel M, and Kubica J. Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes. Eur J Clin Invest 41: 667-671, 2011.
188. Schewe T and Sies H. Myeloperoxidase-induced lipid peroxidation of LDL in the presence of nitrite. Protection by cocoa flavanols. Biofactors 24: 49-58, 2005. (Pubitemid 41750526)
189. Schindhelm RK and van der Zwan LP. Myeloperoxidase as a diagnostic and prognostic marker in cardiology: beware of pre-analytical factors that may influence results. Int J Lab Hematol 33: 332, 2011.
190. Schultz J and Kaminker K. Myeloperoxidase of the leucocyte of normal human blood. I. Content and localization. Arch Biochem Biophys 96: 465-467, 1962.
191. Scirica BM, Sabatine MS, Jarolim P, Murphy SA, de Lemos JL, Braunwald E, and Morrow DA. Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial. Eur Heart J 32: 697-705, 2011.
192. Segal AW. The electron transport chain of the microbicidal oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease. J Clin Invest 83: 1785-1793, 1989. (Pubitemid 19148845)
193. Sinning C, Schnabel R, Peacock WF, and Blankenberg S. Up-and-coming markers: myeloperoxidase, a novel biomarker test for heart failure and acute coronary syndrome application? Congest Heart Fail 14: 46-48, 2008.
194. Soehnlein O, Lindbom L, and Weber C. Mechanisms underlying neutrophil-mediated monocyte recruitment. Blood 114: 4613-4623, 2009.
195. Soehnlein O, Weber C, and Lindbom L. Neutrophil granule proteins tune monocytic cell function. Trends Immunol 30: 538-546, 2009.
196. Soehnlein O, Xie X, Ulbrich H, Kenne E, Rotzius P, Flodgaard H, Eriksson EE, and Lindbom L. Neutrophil-derived heparin-binding protein (HBP/CAP37) deposited on endothelium enhances monocyte arrest under flow conditions. J Immunol 174: 6399-6405, 2005. (Pubitemid 40663833)
197. Spalteholz H, Furtmuller PG, Jakopitsch C, Obinger C, Schewe T, Sies H, and Arnhold J. Kinetic evidence for rapid oxidation of (-)-epicatechin by human myeloperoxidase. Biochem Biophys Res Commun 371: 810-813, 2008.
198. Spalteholz H, Panasenko OM, and Arnhold J. Formation of reactive halide species by myeloperoxidase and eosinophil peroxidase. Arch Biochem Biophys 445: 225-234, 2006. (Pubitemid 43082215)
199. Sperandio M. Selectins and glycosyltransferases in leukocyte rolling in vivo. FEBS J 273: 4377-4389, 2006. (Pubitemid 44401589)
200. Stendahl O, Coble BI, Dahlgren C, Hed J, and Molin L. Myeloperoxidase modulates the phagocytic activity of polymorphonuclear neutrophil leukocytes. Studies with cells from a myeloperoxidase-deficient patient. J Clin Invest 73: 366-373, 1984. (Pubitemid 14194615)
201. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, and Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 158: 879-891, 2001. (Pubitemid 32221781)
202. Sutton MG and Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101: 2981-2988, 2000. (Pubitemid 30415891)
203. Suzuki M, Asako H, Kubes P, Jennings S, Grisham MB, and Granger DN. Neutrophil-derived oxidants promote leukocyte adherence in postcapillary venules. Microvasc Res 42: 125-138, 1991.
204. Szuchman-Sapir AJ, Pattison DI, Davies MJ, and Witting PK. Site-specific hypochlorous acid-induced oxidation of recombinant human myoglobin affects specific amino acid residues and the rate of cytochrome b5-mediated heme reduction. Free Radic Biol Med 48: 35-46, 2010.
205. Tahboub YR, Galijasevic S, Diamond MP, and Abu-Soud HM. Thiocyanate modulates the catalytic activity of mammalian peroxidases. J Biol Chem 280: 26129-26136, 2005. (Pubitemid 41022207)
206. Tang WH, Brennan ML, Philip K, Tong W, Mann S, Van LF, and Hazen SL. Plasma myeloperoxidase levels in patients with chronic heart failure. Am J Cardiol 98: 796-799, 2006. (Pubitemid 44301017)
207. Tang WH, Katz R, Brennan ML, Aviles RJ, Tracy RP, Psaty BM, and Hazen SL. Usefulness of myeloperoxidase levels in healthy elderly subjects to predict risk of developing heart failure. Am J Cardiol 103: 1269-1274, 2009.
208. Tang WH, Tong W, Troughton RW, Martin MG, Shrestha K, Borowski A, Jasper S, Hazen SL, and Klein AL. Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure. J Am Coll Cardiol 49: 2364-2370, 2007. (Pubitemid 46891707)
209. Tavora FR, Ripple M, Li L, and Burke AP. Monocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques. BMC Cardiovasc Disord 9: 27, 2009.
210. Taylor KL, Strobel F, Yue KT, Ram P, Pohl J, Woods AS, and Kinkade JM, Jr. Isolation and identification of a protoheme IX derivative released during autolytic cleavage of human myeloperoxidase. Arch Biochem Biophys 316: 635-642, 1995.
211. Tiden AK, Sjogren T, Svensson M, Bernlind A, Senthilmohan R, Auchere F, Norman H, Markgren PO, Gustavsson S, Schmidt S, Lundquist S, Forbes LV, Magon NJ, Paton LN, Jameson GN, Eriksson H, and Kettle AJ. 2-Thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation. J Biol Chem 286: 37578-37589, 2011.
212. Tien M. Myeloperoxidase-catalyzed oxidation of tyrosine. Arch Biochem Biophys 367: 61-66, 1999. (Pubitemid 29394193)
213. Tiruppathi C, Naqvi T, Wu Y, Vogel SM, Minshall RD, and Malik AB. Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cells. Proc Natl Acad Sci U S A 101: 7699-7704, 2004. (Pubitemid 38658092)
214. Tobler A, Miller CW, Johnson KR, Selsted ME, Rovera G, and Koeffler HP. Regulation of gene expression of myeloperoxidase during myeloid differentiation. J Cell Physiol 136: 215-225, 1988.
215. Torre D, Ferrario G, Speranza F, Orani A, Fiori GP, and Zeroli C. Serum concentrations of nitrite in patients with HIV-1 infection. J Clin Pathol 49: 574-576, 1996. (Pubitemid 26232733)
216. Tsimikas S and Miller YI. Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease. Curr Pharm Des 17: 27-37, 2011.
217. Undurti A, Huang Y, Lupica JA, Smith JD, DiDonato JA, and Hazen SL. Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle. J Biol Chem 284: 30825-30835, 2009.
218. Ungvari Z, Gupte SA, Recchia FA, Batkai S, and Pacher P. Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. Curr Vasc Pharmacol 3: 221-229, 2005. (Pubitemid 40933045)
219. Urban CF, Ermert D, Schmid M, bu-Abed U, Goosmann C, Nacken W, Brinkmann V, Jungblut PR, and Zychlinsky A. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog 5: e1000639, 2009.
220. Van AP, Slomianny MC, Boudjeltia KZ, Delporte C, Faid V, Calay D, Rousseau A, Moguilevsky N, Raes M, Vanhamme L, Furtmuller PG, Obinger C, Vanhaeverbeek M, Neve J, and Michalski JC. Glycosylation pattern of mature dimeric leukocyte and recombinant monomeric myeloperoxidase: glycosylation is required for optimal enzymatic activity. J Biol Chem 285: 16351-16359, 2010.
221. van Dalen CJ and Kettle AJ. Substrates and products of eosinophil peroxidase. Biochem J 358: 233-239, 2001. (Pubitemid 32778118)
222. van Dalen CJ, Whitehouse MW, Winterbourn CC, and Kettle AJ. Thiocyanate and chloride as competing substrates for myeloperoxidase. Biochem J 327 (Pt 2): 487-492, 1997. (Pubitemid 27477827)
223. van Dalen CJ, Winterbourn CC, Senthilmohan R, and Kettle AJ. Nitrite as a substrate and inhibitor of myeloperoxidase. Implications for nitration and hypochlorous acid production at sites of inflammation. J Biol Chem 275: 11638-11644, 2000. (Pubitemid 30237723)
224. Van der Veen BS, de Winther MP, Heeringa P, Augusto O, Chen JW, Davies M, Ma XL, Malle E, Pignatelli P, and Rudolph T. Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal 11: 2899-2937, 2009.
225. Van der Vliet A, Eiserich JP, Halliwell B, and Cross CE. Formation of reactive nitrogen species during peroxidasecatalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem 272: 7617-7625, 1997. (Pubitemid 27137309)
226. van Zyl JM, Basson K, Uebel RA, and van der Walt BJ. Isoniazid-mediated irreversible inhibition of the myeloperoxidase antimicrobial system of the human neutrophil and the effect of thyronines. Biochem Pharmacol 38: 2363-2373, 1989. (Pubitemid 19173879)
227. Vicca S, Massy ZA, Hennequin C, Rihane D, Drueke TB, and Lacour B. Apoptotic pathways involved in U937 cells exposed to LDL oxidized by hypochlorous acid. Free Radic Biol Med 35: 603-615, 2003. (Pubitemid 37101128)
228. Vissers MC and Winterbourn CC. Myeloperoxidase-dependent oxidative inactivation of neutrophil neutral proteinases and microbicidal enzymes. Biochem J 245: 277-280, 1987.
229. Vlasova II, Arnhold J, Osipov AN, and Panasenko OM. pHdependent regulation of myeloperoxidase activity. Biochemistry (Mosc) 71: 667-677, 2006.
230. Voetman AA,Weening RS, HamersMN,Meerhof LJ, Bot AA, and Roos D. Phagocytosing human neutrophils inactivate their own granular enzymes. J Clin Invest 67: 1541-1549, 1981. (Pubitemid 11099371)
231. Wang JG, Mahmud SA, Nguyen J, and Slungaard A. Thiocyanate-dependent induction of endothelial cell adhesion molecule expression by phagocyte peroxidases: a novel HOSCN-specific oxidant mechanism to amplify inflammation. J Immunol 177: 8714-8722, 2006. (Pubitemid 44893837)
232. Wang Y, Rosen H, Madtes DK, Shao B, Martin TR, Heinecke JW, and Fu X. Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue: an oxidative mechanism for regulating proteolysis during inflammation. J Biol Chem 282: 31826-31834, 2007. (Pubitemid 350106428)
233. Whitman SC, Hazen SL, Miller DB, Hegele RA, Heinecke JW, and Huff MW. Modification of type III VLDL, their remnants, and VLDL from ApoE-knockout mice by p-hydroxyphenylacetaldehyde, a product ofmyeloperoxidase activity, causes marked cholesteryl ester accumulation in macrophages. Arterioscler Thromb Vasc Biol 19: 1238-1249, 1999. (Pubitemid 29227643)
234. Winterbourn CC. Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxidechloride, and similarity of the oxidant to hypochlorite. Biochim Biophys Acta 840: 204-210, 1985. (Pubitemid 15049536)
235. Winterbourn CC. Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid. Toxicology 181-182: 223-227, 2002. (Pubitemid 36015703)
236. Winterbourn CC, Garcia RC, and Segal AW. Production of the superoxide adduct of myeloperoxidase (compound III) by stimulated human neutrophils and its reactivity with hydrogen peroxide and chloride. Biochem J 228: 583-592, 1985. (Pubitemid 15011507)
237. Winterbourn CC, Hampton MB, Livesey JH, and Kettle AJ. Modeling the reactions of superoxide and myeloperoxidase in the neutrophil phagosome: implications for microbial killing. J Biol Chem 281: 39860-39869, 2006. (Pubitemid 46041789)
238. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, and Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 80: 617-653, 2000.
239. Wong ND, Gransar H, Narula J, Shaw L, Moon JH, Miranda- Peats R, Rozanski A, Hayes SW, Thomson LE, Friedman JD, and Berman DS. Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events. JACC Cardiovasc Imaging 2: 1093-1099, 2009.
240. Ximenes VF,Maghzal GJ, Turner R, Kato Y,Winterbourn CC, and Kettle AJ. Serotonin as a physiological substrate for myeloperoxidase and its superoxide-dependent oxidation to cytotoxic tryptamine-4,5-dione. Biochem J 425: 285-293, 2010.
241. Zamocky M, Jakopitsch C, Furtmuller PG, Dunand C, and Obinger C. The peroxidase-cyclooxygenase superfamily: reconstructed evolution of critical enzymes of the innate immune system. Proteins 72: 589-605, 2008. (Pubitemid 351928514)
242. Zarbock A and Ley K. Neutrophil adhesion and activation under flow. Microcirculation 16: 31-42, 2009.
243. Zederbauer M, Jantschko W, Neugschwandtner K, Jakopitsch C, Moguilevsky N, Obinger C, and Furtmuller PG. Role of the covalent glutamic acid 242-heme linkage in the formation and reactivity of redox intermediates of human myeloperoxidase. Biochemistry 44: 6482-6491, 2005. (Pubitemid 40593799)
244. Zeng J and Fenna RE. X-ray crystal structure of canine myeloperoxidase at 3 A resolution. J Mol Biol 226: 185-207, 1992.
245. Zhang C, Patel R, Eiserich JP, Zhou F, Kelpke S, Ma W, Parks DA, Darley-Usmar V, and White CR. Endothelial dysfunction is induced by proinflammatory oxidant hypochlorous acid. Am J Physiol Heart Circ Physiol 281: H1469-H1475, 2001.
246. Zhang C, Reiter C, Eiserich JP, Boersma B, Parks DA, Beckman JS, Barnes S, Kirk M, Baldus S, Darley-Usmar VM, and White CR. L-arginine chlorination products inhibit endothelial nitric oxide production. J Biol Chem 276: 27159-27165, 2001.
247. 2-induced apoptosis via down-regulation of reactive oxygen species in cardiac myocytes. Mol Cell Biochem 347: 21-28, 2011.
248. Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, Topol EJ, Sprecher DL, and Hazen SL. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286: 2136-2142, 2001. (Pubitemid 34041599)
249. Zheng L, Nukuna B, Brennan ML, Sun M, Goormastic M, Settle M, Schmitt D, Fu X, Thomson L, Fox PL, Ischiropoulos H, Smith JD, Kinter M, and Hazen SL. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 114: 529-541, 2004. (Pubitemid 39572103)
250. Zou MH, Shi C, and Cohen RA. Oxidation of the zincthiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109: 817-826, 2002. (Pubitemid 34263158)